Lv1
60 积分 2025-09-05 加入
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment
16小时前
待确认
Application of new approach methodologies for nonclinical safety assessment of drug candidates
16小时前
已完结
Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach
16小时前
已完结
Alkaline comet assay in liver and stomach, and micronucleus assay in bone marrow, from rats treated with 2-acetylaminofluorene, azidothymidine, cisplatin, or isobutyraldehyde
3天前
已完结
Applications of in vitro new approach methodologies (NAMs) in drug development: A scoping analysis of titles of nonclinical study reports submitted to the FDA
6天前
已完结
High-resolution 3D imaging of fixed and cleared organoids
8天前
已完结
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
10天前
已完结
Organoids and organ-on-a-chip platforms for advancing oligonucleotide drug development
1个月前
已完结
OS03-03 A blueprint for the future: first EMA's Qualification Opinion for a NAM in toxicity assessment – towards regulatory acceptance of Virtual Control Groups (VCGs) through the IHI VICT3R project
1个月前
已完结
Advances in New Approach Methodologies at FDA 's Division of Applied Regulatory Science
1个月前
已完结
皖公网安备34019202002308
